Website
master-nanomed.eu
Budget
€ 3.160.000,00
Project
NANOMED – Nanomedicine for Drug DeliveryUNIPV structure involved
Department of Drug SciencesUNIPV Team
prof. Carla Caramella, prof. Bice Conti, prof. Marco TerreniProject Duration
4 consecutive intakesStart Date: 15 Sep 2020
End Date: 15 Sep 2025Coordinator
Paris Descartes University – FranceFull Partners
University of Patras – Greece, University of Pavia – Italy, University of Angers – FranceAcademic associate partners: Galien Institute School of Pharmacy, University of Paris Sud (France), University of Bourgogne (France), University of Nantes (France), ICGM, University of Montpellier (France), University of Turin (Italy), University of Louvain (Belgium), University of Athens (Greece), University of Strasbourg (France), University of Caen (France), University of Tours (France) University of Liège (Belgium), University of Navarra (Spain), University of Granada (Spain), University of Columbia (USA)
Non-academic associate partners: Foundation for Research and Technology Hellas, Institute of Chemical Engineering Sciences, (FORTH/ICE-HT), CARLINA technologies, GATTEFOSSE, GUERBET, SANOFI, DEMO PHARMACEUTICALS, ELPEN, VERISFIELD, Proxagen, The European Technology Platform for Nanomedicine (ETPN), The Society of Drug Delivery Sciences and Technology (APGI), The French Society of Nanomedicine (SF Nano), the Greek Chapter of the Controlled Release Society and the Panhellenic Pharmaceutical Union (PEF), the Italian Chapter of the Controlled Release Society (CRS) and the Italian Association of Industrial Pharmacists (AFI), The BeNeLux & France chapter of the Controlled Release Society (CRS), Pierre Fabre Fondation
The Nanomedicine for Drug Delivery NANOMED EMJMD is a 22-months-long curriculum offering a high quality education in the emerging field of Nanomedicine.
The design of nanomedicines for drug delivery requires combining knowledge from Pharmacy, Biology, Chemistry, Medicine, Physics and Engineering which makes the NANOMED EMJMD a highly multidisciplinary Master’s degree. The frame of the EMJMD has thus been elaborated in order to be able to welcome students from different backgrounds who would show an interest in the field of Nanomedicine.
NANOMED aims at filing the gap between basic training in Drug Delivery currently provided by most Schools of Pharmacy at Master level and advanced knowledge in Nanomedicine required for post-graduate young scientists. Participating to the NANOMED EMJMD will thus be a great opportunity for future graduates to tackle Nanomedicine through multi-disciplinary perspectives and to be able to integrate the progress made in the field of Nanotechnology on the development of Advanced Particulate Drug Delivery Systems.
NANOMED provides both theoretical and practical knowledge for 3 semesters (Semesters 1, 2 and 3, 30 ECTS each) combined with a final traineeship (Semester 4, 30 ECTS).